BMCMI
PFE icon

Bryn Mawr Capital Management Inc’s Pfizer PFE Stock Holding History

Bryn Mawr Capital Management Inc’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-110,670
Closed -$3.1M – 588
2014
Q3 		$3.1M Sell
110,670
-2,108
-2% -$59.2K 0.32% 94
2014
Q2 		$3.18M Buy
112,778
+18,919
+20% +$539K 0.3% 108
2014
Q1 		$2.86M Buy
+93,859
New +$2.8M 0.26% 128
2013
Q3 		– Sell
-533,407
Closed -$14.2M – 604
2013
Q2 		$14.2M Buy
+533,407
New +$14.7M 0.95% 23

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bryn Mawr Capital Management Inc's PFE Position: Q4 2014 in Review

Bryn Mawr Capital Management Inc sold out of Pfizer (PFE) in Q4 2014, closing a stake of 110,670 shares — an estimated $3.1M sold.

Bryn Mawr Capital Management Inc first reported a position in PFE in Q2 2013 and held it in 4 quarters. The position peaked at $14.2M in Q2 2013. 1,860 funds tracked by Wall St. Rank hold PFE as of Q4 2014.

  • Bryn Mawr Capital Management Inc reported no remaining Pfizer position as of Q4 2014 after selling out during the quarter.
  • Bryn Mawr Capital Management Inc sold 110,670 Pfizer shares in Q4 2014, an estimated $3.1M.
  • Bryn Mawr Capital Management Inc first reported a position in Pfizer in Q2 2013 and held it in 4 quarters.
  • Bryn Mawr Capital Management Inc's Pfizer position peaked at $14.2M in Q2 2013.
  • 1,860 funds tracked by Wall St. Rank held Pfizer as of Q4 2014.

Based on Bryn Mawr Capital Management Inc's 13F filing for Q4 2014, filed 13 Feb 2015.